In this study, we examine from multiple perspectives, women's shared decision-making
needs when considering cervical screening options: Pap testing, in-clinic human …

ABSTRACT Knowledge about Human Papilloma Virus (HPV), timely screening programs
and early vaccination are crucial to prevent cervical cancer. Existing studies have reported a …

Background In Greenland, the incidence of cervical cancer caused by human papillomavirus
(HPV) is 25 per 100,000 women; 2.5 times the Danish rate. In Greenland, the disease is …

Objective To examine the impact of self‐reported human papillomavirus (HPV) test result
(HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes …

Objectives Human papillomavirus is one of the most important causes of cervical cancer.
Participating in an HPV test and receiving an HPV diagnosis can create questions about the …

Purpose Current cervical cancer screening guidelines recommend 3-year screening
intervals, in contrast to the previous recommendation of annual screening, to prevent over …

Background The human papillomavirus (HPV) test, administered alone without the
Papanicolaou (Pap) test, was recently recognized as a cervical cancer screening option in …

Objective To explore emotional responses, and predictors of negative reactions, among
women undergoing human papillomavirus (HPV) tests in routine clinical practice. Design …

Abstract Knowledge of cervical cancer and HPV testing are important factors in proactive
and continued engagement with screening and are critical considerations as countries move …

As Canadian provinces and territories prepare to transition to HPV-based primary screening
for cervical cancer, failure to identify and address potential barriers to screening could …